Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
30,242
Value
$9.10M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,242$9.10M0.1%+371+1.2%AddedHolders
Q1 202629,871$9.88M0.1%+2,543+9.3%AddedHolders
Q4 202527,328$10.9M0.1%+1,176+4.5%AddedHolders
Q3 202526,152$11.9M0.1%+1,135+4.5%AddedHolders
Q2 202525,017$8.16M0.1%+1,860+8.0%AddedHolders
Q1 202523,157$6.25M0.1%+701+3.1%AddedHolders
Q4 202422,456$5.28M<0.1%+1,806+8.7%AddedHolders
Q3 202420,650$5.68M0.1%−426−2.0%ReducedHolders
Q2 202421,076$5.12M0.1%+1,378+7.0%AddedHolders
Q1 202419,698$2.94M<0.1%+5,609+39.8%AddedHolders
Q4 202314,089$2.70M<0.1%−895−6.0%ReducedHolders
Q3 202314,984$2.65M<0.1%+109+0.7%AddedHolders
Q2 202314,875$2.83M<0.1%−1,963−11.7%ReducedHolders
Q1 202316,838$3.37M<0.1%+161+1.0%AddedHolders
Q4 202216,677$3.96M0.1%+2,352+16.4%AddedHolders
Q3 202214,325$2.87M0.1%+22+0.2%AddedHolders
Q2 202214,303$2.09M<0.1%+520+3.8%AddedHolders
Q1 202213,783$2.25M<0.1%+387+2.9%AddedHolders
Q4 202113,396$2.27M<0.1%+9+0.1%AddedHolders
Q3 202113,387$2.53M<0.1%−326−2.4%ReducedHolders
Q2 202113,713$2.33M<0.1%+1,658+13.8%AddedHolders
Q1 202112,055$1.70M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.